Influence of sex on the outcomes of uniportal video‑assisted thoracoscopic sympathicotomy for primary palmar hyperhidrosis [PDF]
Videosurgery and Other Miniinvasive TechniquesIntroduction: Primary palmar hyperhidrosis (PPH) impairs the quality of life. Video ‑assisted thoracoscopic sympathicotomy is an effective treatment method; however, the impact of sex on surgical outcomes according to the denervation level (T3 vs T3–T4 ...
Turkan Dubus +2 more
doaj +3 more sources
Cosmetics, 2021 Hyperhidrosis, or excessive sweating, negatively impacts patients both physically and psychologically. It may be primary or secondary: the primary form is a benign condition, with its growing prevalence reaching 5% recently.
Ghadah Alhetheli
doaj +2 more sources
Altered Th17/Treg balance and therapeutic targeting of RORγ in primary focal hyperhidrosis [PDF]
Frontiers in ImmunologyBackgroundPrimary focal hyperhidrosis (PFH) significantly impacts patients’ physical and mental health, yet its underlying mechanisms remain unclear.MethodsThis study involved 80 healthy controls and 60 patients each with primary palmar (PPH ...
Min Lin +9 more
doaj +2 more sources
Development and validation of a model for predicting depression risk in primary palmar hyperhidrosis: a cross-sectional retrospective observational study [PDF]
BMJ OpenObjective Primary palmar hyperhidrosis (PPH), characterised by excessive palm sweating, significantly impacts patients’ physiology, psychology, self-esteem, work, life and social interactions.
Xiaoyu Wang, Yuqing Huang
doaj +2 more sources
Compensatory hyperhidrosis following endoscopic thoracic sympathectomy: a 5-year follow-up study of risk factors and symptom progression [PDF]
Journal of Cardiothoracic SurgeryBackground Compensatory hyperhidrosis (CH) is a common complication after endoscopic thoracic sympathectomy (ETS) for hyperhidrosis. Despite its prevalence, long-term data on CH progression and associated risk factors are scarce.
Jian-Yang Wu +7 more
doaj +2 more sources
Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis. [PDF]
Dermatol Res Pract, 2013 Background. Two preparations of botulinum A toxin (BTX‐A) are commercially available for the treatment of palmar hyperhidrosis (PPH): Botox (Allergan; 100 U/vial) and Dysport (Ipsen Limited; 500 U/vial), which are not bioequivalent. Results regarding an appropriate conversion factor between them are controversial. Objectives. This paper aims to compare
El Kahky HM, Diab HM, Aly DG, Farag NM.
europepmc +2 more sources
Long term outcomes and risk factors of compensatory hyperhidrosis after thoracoscopic sympathectomy in primary palmar hyperhidrosis patients: a retrospective single-center study [PDF]
Journal of Cardiothoracic SurgeryObjective This study aims to evaluate the long-term outcomes of compensatory hyperhidrosis (CH) after thoracoscopic sympathectomy and explore the risk factors affecting postoperative CH in primary palmar hyperhidrosis(PPH) patients.
Jianxin Xu +6 more
doaj +2 more sources
Comparison of CT-guided thoracic sympathetic nerve block and radiofrequency in the treatment of primary palmar hyperhidrosis. [PDF]
Front Surg, 2023 Zhang L +5 more
europepmc +2 more sources
Anatomical variations of the thoracic sympathetic ganglions and their effects on sympathicotomy for primary palmar hyperhidrosis. [PDF]
Clin Auton Res, 2023 Pei G +6 more
europepmc +2 more sources
, 2023 Primary palmar hyperhidrosis (PPH) can be challenging for both patient and physician. Botulinum toxin type A (BTX-A) injection has been shown to be useful in treating PPH, whilst it causes pain and discomfort in most of the patient.
Sarah Diba +2 more
core +1 more source